carbapenems has been researched along with Adverse Drug Event in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Ge, W; Hu, H; Li, C; Wang, L; Xia, J | 1 |
Hagiya, H; Hamaguchi, S; Kokado, R; Morii, D; Okuno, H; Tomono, K; Ueda, A; Yamamoto, N; Yoshida, H | 1 |
Ang, B; Lew, EL; Lew, KY; Ling, LM; Lye, D; Ng, TM; Tan, M; Tan, SH; Teng, CB | 1 |
Hussar, DA | 1 |
File, TM; Redman, R | 1 |
Bailey, WJ; Chibout, SD; Clouse, HK; Cordier, A; Dieterle, F; Erdos, Z; Forest, T; Gerhold, DL; Glaab, WE; Grenet, O; Holder, D; Jin, H; Legay, F; Mahl, A; Maurer, G; Muniappa, N; Ozer, JS; Perentes, E; Reynolds, S; Roth, DR; Sina, JF; Sistare, FD; Skopek, TR; Staedtler, F; Thudium, DT; Topper, MJ; Troth, S; Verdes, P; Vlasakova, K; Vonderscher, J; Wahl, D; Yu, Y | 1 |
6 other study(ies) available for carbapenems and Adverse Drug Event
Article | Year |
---|---|
Safety profile of carbapenems: Data mining of the FDA adverse events reporting system.
Topics: Adverse Drug Reaction Reporting Systems; Bayes Theorem; Carbapenems; Data Mining; Drug-Related Side Effects and Adverse Reactions; Humans; Retrospective Studies; United States; United States Food and Drug Administration | 2021 |
Association of Adverse Drug Events with Broad-spectrum Antibiotic Use in Hospitalized Patients: A Single-center Study.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Vancomycin; Young Adult | 2019 |
Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Therapy; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Endemic Diseases; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Patient Readmission; Retrospective Studies; Survival Analysis; Treatment Outcome | 2015 |
New drugs08, part 2.
Topics: Acromegaly; Adult; Anti-Bacterial Agents; Anti-HIV Agents; Antineoplastic Agents; Biopterins; Carbapenems; Child; Child, Preschool; Cyclohexanes; Doripenem; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Epothilones; Humans; Infant; Maraviroc; Peptides, Cyclic; Pharmaceutical Preparations; Phenylketonurias; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Sirolimus; Somatostatin; Triazoles | 2008 |
Safety of intravenous infusion of doripenem.
Topics: Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cross Infection; Doripenem; Drug Stability; Drug-Related Side Effects and Adverse Reactions; Humans; Hypersensitivity; Infusions, Intravenous; Injections, Intravenous; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Quality Control | 2009 |
A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function.
Topics: Animals; Biomarkers, Pharmacological; Blood Urea Nitrogen; Carbapenems; Creatinine; Cystatin C; Drug-Related Side Effects and Adverse Reactions; Female; Gentamicins; Kidney; Kidney Diseases; Kidney Function Tests; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; ROC Curve | 2010 |